[Op-Ed: Transformation] Mark Cuban’s Maverick Drug Company

Microdosing
06/09/2022 10 min Temporada 5 Episodio 4

Listen "[Op-Ed: Transformation] Mark Cuban’s Maverick Drug Company"

Descargar episodio Ver en sitio original

Episode Synopsis

Mark Cuban's "Cost Plus Drug Company" is on a mission to "disrupt the drug industry".  When a big name makes big promises the healthcare industry normally gets either excited or cringes.  However, I'm finding it's doing neither.  In this episode, we share some thoughts and opinions as to why that is.

More episodes of the podcast Microdosing

Building a Better Backbone and the Role of Primary Care in the US 06/01/2026
Workforce Reconfiguration, Not Workforce Shortage; It’s not people and patient ratios, it’s the care model and sub-models themselves 23/12/2025
The Naming Maze; How Getting Lost in Healthcare Taxonomy and Wayfinding Costs Millions 18/12/2025
Where Journeys Collide; Designing Beyond a Single Healthcare Experience Map 02/12/2025
The Monster in the Middle; Why Prior Authorization Wrecks the Patient Experience, and Why Everyone’s Trying to Tame It 29/11/2025
The Decentralizing of the Hospital Cafeteria; Why food service is the next frontier of healthcare innovation 18/11/2025
The Quiet Rebellion; How Small Medical Practices Are Beating the Odds and Finding Margin in the Chaos 04/11/2025
Medication Management and the Myth of Patient Empowerment 28/10/2025
Modern Primary Care Diagnostic Sequences 21/10/2025
The Next Safety Gap; How Compounded GLP-1s Expose the Limits of Oversight 14/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA